Beyond ice: rethinking Australia's approach to illicit drugs

Matthew Y Frei and Alex D Wodak
Med J Aust 2017; 206 (4): 151-152. || doi: 10.5694/mja16.00108

Redefining drug use as a health and social issue within a harm reduction framework will require progressive policy

Crystalline methylamphetamine (“ice”) was widely discussed in Australia in 2015. At the beginning of 2016, the federal government National Ice Taskforce report1 and Prime Minister Turnbull’s response to the report2 attracted substantial media attention. Twelve months on, are the report’s recommendations, the funding pledged and the government’s response likely to reduce the toll of ice on the Australian community?

Please login with your free MJA account to view this article in full

  • Matthew Y Frei1
  • Alex D Wodak2

  • 1 Turning Point, Eastern Health, Melbourne, VIC
  • 2 Alcohol and Drug Service, St Vincent's Hospital, Sydney, NSW

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

access_time 12:30, 13 March 2017
George L Rubin

Excellent article. Would perhaps be useful to articulate for discussion the major barriers that need to be overcome to make progress as suggested for this health problem?

Competing Interests: No relevant disclosures

Prof George L Rubin
South Eastern Sydney Local Health District

Responses are now closed for this article.